期刊文献+

BLyS受体TACI、BCMA与人IgG1 Fc融合蛋白在哺乳动物细胞中的表达与鉴定 被引量:6

Expression and identification of TACI/BCMA-IgG1 Fc fusion proteins in mamamlian cells
暂未订购
导出
摘要 从人肝脏和肾脏cDNA文库中扩增了人IgG1Fc与B淋巴细胞刺激因子 (BLyS)的受体TACI及BCMA的胞外编码区 ,构建了TACI Fc及BCMA Fc融合表达质粒pSec1 Fc TACI与 pSec1 Fc BCMA ,并使用电穿孔法转染COS 7细胞 ,从 1L无血清培养上清中可纯化得到分泌表达的TACI Fc与BCMA Fc融合蛋白约 2mg。为获得TACI Fc与BCMA Fc的稳定来源 ,构建了TACI Fc与BCMA Fc的CHO稳定表达细胞株。免疫沉淀和ELISA结果显示 ,TACI Fc及BCMA Fc能特异性地结合其配体BLyS而不与BLyS同家族的TNF结合。TACI Fc及BCMA The cDNA of human IgG1 Fc and the extracelluar domains of the receptors of B lymphocyte stimulator (BLyS), TACI and BCMA, were amplified from cDNA libraries of human liver and kidney. The secretory expression plasmids of TACI Fc and BCMA Fc fusion proteins were constructed and transfected to COS 7 cells by electroporation. About 2 mg of purified fusion proteins were obtained from 1 liter of serum free cell culture supernatant. Stable CHO cell lines which express TACI Fc and BCMA Fc were also constructed. Immunoprecipitation and ELISA demonstrated that TACI Fc and BCMA Fc specifically bind to BLyS but not to TNF, which belongs to the same superfamily of BLyS. The stimulation of mouse B lymphocyte triggered by BLyS can be inhibited with TACI Fc and BCMA Fc in vitro .
出处 《动物学报》 SCIE CAS CSCD 北大核心 2004年第3期401-407,共7页 ACTA ZOOLOGICA SINICA
基金 "8 63"计划资助项目 (No 2 0 0 1AA2 15 3 81)~~
关键词 融合蛋白 哺乳动物细胞 表达 鉴定 肝脏 肾脏 CDNA BlyS,TACI,BCMA,Fc,Fusion protein,Mammalian cell
  • 相关文献

参考文献19

  • 1Cheema GS, Roschke V, Hilbert DM, Stohl W, 2001. Elevated serum B lymphocyte stimulator levels in patients with systemic immunebased rheumatic diseases. Arthritis. Rheum. 44 (6): 1313-1 319.
  • 2Do RKG, Hatada E, Lee H, Tourigny MR, Hilbert D, Chen-Kiang S,2000. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med. 192(7): 953-964.
  • 3Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, Tschopp J, Cachero TG, Batten M, Wheway J, Mauri D,Cavill D, Gordon TP, Mackay CR, Mackay F, 2002. Association of BAFF/BlyS overexpression and altered B cell differentiation with SjOgren's
  • 4Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K,Xu W, Parrish-Novak J, Foster D, Lofton-Day C, Moore M, Littau A, Grossman A, Haugen H, Foley K, Blumberg H, Harrison K, Kindsvogel W, Clegg CH, 2000. TACI and BCMA are receptors for a TNF hom
  • 5Julius MH, Simpson E, Herzenberg LA, 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J.Immunol. (3): 645-649.
  • 6Kayagaki N, Yan M, Seshasayee D, Wang H, Lee W, French DM,Grewal IS, Cochran AG, Gordon NC, Yin J, Starovasnik MA,Dixit VM, 2002. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of
  • 7Khare SD, Sarosi I, Xia XZ, McCabe S, Miner K, Solovyev I,Hawkins N, Kelley M, Chang D, Van G, Ross L, Delaney J,Wang L, Lacey D, Boyle WJ, Hsu H, 2000. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc.Natl. Acad. Sci. USA9
  • 8Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M,Schneider P, Tschopp J, Browning JL, 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190 (11): 1 697-1 710.
  • 9Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM, Ashkenazi A,2000. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr. Biol. 10(13): 785-788.
  • 10Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, Soppet D, Charters M, Gentz R, Parmelee D, Li Y, Galperina O,Giri J, Roschke V, Nardelli B, Carrell J, Sosnovtseva S, Greenfield W, Ruben SM, Olsen HS, Fikes J, Hilbert DM, 1999.BLyS: member of th

同被引文献58

  • 1Shou-LiangGong,GangZhao,Hong-GuangZhao,Wen-TianLü,Guang-WeiLiu,PingZhu.Ability of luteinizing hormone releasing hormone-Pseudomonas aeruginosa exotoxin 40 binding to LHRH receptor on human liver cancer cells[J].World Journal of Gastroenterology,2004,10(19):2870-2873. 被引量:8
  • 2杨建军,张昕泂,周洁,龚振,陶群,叶丹,汪世龙,鞠佃文.rhEPO-Fc融合蛋白的表达、纯化及质量研究[J].中国生物工程杂志,2007,27(6):6-9. 被引量:7
  • 3Yousef GM, Diamandis EP. An overview of the kallikrein gene families in humans and other species: emerging candidate tumor markers. Clin Biochem, 2003, 36(6): 443.
  • 4Fukushima D, Kitamura N, Nakanishi S. Nucleotide sequence of cloned cDNA for human pancreatic kallikrein. Biochemistry, 1985, 24(27): 8037-8043.
  • 5Barker AR, Shine J. Human kidney kallikrein: cDNA cloning and sequence analysis. DNA, 1985, 4(6): 445-450.
  • 6Chao J, Woodley C, Chao L, et al. Identification of tissue kallikrein in brain and in the cell-free translation product encoded by brain mRNA. J Biol Chem, 1983, 258(24): 15173-15178.
  • 7Nolly H, Scicli AG, Scicli G, et al. Characterization of a kininogenase from rat vascular tissue resembling tissue kallikrein. Circ Res, 1985, 56(6): 816-821.
  • 8Evans BA, Yun ZX, Close JA, et al. Structure and chromosomal localization of the human renal kallikrein gene. Biochemistry, 1988, 27(9): 3124-3129.
  • 9Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev, 1992, 44(1): 1-80.
  • 10Pesquero JB, Bader M. Molecular biology of the kallikrein-kinin system: from structure to function. Braz J Med Biol Res, 1998, 31(9): 1197-1203.

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部